# Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin

> **NCT00979056** · PHASE3 · COMPLETED · sponsor: **Dr. Philipp Zanger, MD MSc DTM** · enrollment: 258 (actual)

## Conditions studied

- Diarrhoea

## Interventions

- **DRUG:** Rifaximin
- **DRUG:** Lactose

## Key facts

- **NCT ID:** NCT00979056
- **Lead sponsor:** Dr. Philipp Zanger, MD MSc DTM
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-10
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979056, "Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00979056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*